期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
脑卒中后吞咽障碍患者行含益生菌肠内营养支持的疗效观察
1
作者 沈敏瑾 胡春晓 卢翀 《世界华人消化杂志》 CAS 2023年第4期150-156,共7页
背景营养不良是脑卒中(cerebralvascular accident,CVA)患者预后不良的独立危险因素,但单纯肠内营养支持难以保证营养物质的及时消化吸收,而含益生菌肠内营养支持是改善胃肠道功能,提高营养物质吸收的有效手段,可用于脑卒中后吞咽障碍患... 背景营养不良是脑卒中(cerebralvascular accident,CVA)患者预后不良的独立危险因素,但单纯肠内营养支持难以保证营养物质的及时消化吸收,而含益生菌肠内营养支持是改善胃肠道功能,提高营养物质吸收的有效手段,可用于脑卒中后吞咽障碍患者.目的探讨CVA后吞咽障碍患者含益生菌肠内营养支持疗效.方法选取2017-09/2020-10我院脑卒中后吞咽障碍患者106例,以随机数字表法分为观察组(n=53)、对照组(n=53).对照组采取常规肠内营养支持,观察组采取含益生菌肠内营养支持,均治疗2 wk.比较两组治疗前、治疗1 wk、2 wk后营养参数[血红蛋白(hemoglobin,Hb)、白蛋白(albumin,ALB)、总蛋白(total protein,TP)]、免疫功能指标[外周血总淋巴计数(total lymphocyte count,TLC)与血清免疫球蛋白M(immunoglobulin M,IgM)、免疫球蛋白G(immunoglobulin G,IgG)、免疫球蛋白A(immunoglobulin A,IgA)]、美国国立卫生院神经功能缺损量表(national institutes of health neurological deficit scale,NIHSS)、急性生理学及慢性健康状况评分系统Ⅱ(acute physiology and chronic health scoring systemⅡ,APACHEⅡ)评分、肠道屏障功能指标[二胺氧化酶(diamine oxidase,DAO)、D-乳酸(D-lactic acid,D-LA)]水平,并统计胃肠道并发症发生情况、住院时间、住院费用.结果观察组治疗1 wk、2 wk后外周血TLC与血清IgM、IgG、IgA、Hb、ALB、TP水平均高于对照组(P<0.05);观察组治疗1 wk、2 wk后NIHSS、APACHEⅡ评分及血清DAO、D-LA水平均低于对照组(P<0.05);观察组住院时间短于对照组,胃肠道并发症发生率及住院费用低于对照组(P<0.05).结论含益生菌肠内营养支持应用于脑卒中后吞咽障碍患者中,可有效减少胃肠道并发症发生,改善患者营养状态及免疫功能,促进肠道屏障功能恢复,缩短康复进程,且医疗费用较低,值得临床推广与应用. 展开更多
关键词 脑卒中后吞咽障碍 肠内营养支持 益生菌 康复进程
下载PDF
Low-pressure pneumoperitoneum with abdominal wall lift in laparoscopic total mesorectal excision for rectal cancer:initial experience 被引量:4
2
作者 Ping-Tian Xia Maimaiti Yusofu +4 位作者 Hai-Feng Han chun-xiao hu San-Yuan hu Wen-Bin Yu Shao-Zhuang Liu 《World Journal of Gastroenterology》 SCIE CAS 2018年第11期1278-1284,共7页
AIM To evaluate the safety and feasibility of a new technology combining low-pressure pneumoperitoneum(LPP) and abdominal wall lift(AWL) in laparoscopic total mesorectal excision(TME) for rectal cancer.METHODS From No... AIM To evaluate the safety and feasibility of a new technology combining low-pressure pneumoperitoneum(LPP) and abdominal wall lift(AWL) in laparoscopic total mesorectal excision(TME) for rectal cancer.METHODS From November 2015 to July 2017,26 patients underwent laparoscopic TME for rectal cancer using LPP(6-8 mm Hg) with subcutaneous AWL in Qilu Hospital of Shandong University,Jinan,China.Clinical data regarding patients' demographics,intraoperative monitoring indices,operation-related indices andpathological outcomes were prospectively collected.RESULTS Laparoscopic TME was performed in 26 cases(14 anterior resection and 12 abdominoperineal resection) successfully,without conversion to open or laparoscopic surgery with standard-pressure pneumoperitoneum.Intraoperative monitoring showed stable heart rate,blood pressure and paw airway pressure.The mean operative time was 194.29 ± 41.27 min(range:125-270 min) and 200.41 ± 20.56 min(range:170-230 min) for anterior resection and abdominoperineal resection,respectively.The mean number of lymph nodes harvested was 16.71 ± 5.06(range:7-27).There was no positive circumferential or distal resection margin.No local recurrence was observed during a median follow-up period of 11.96 ± 5.55 mo(range:5-23 mo).CONCLUSION LPP combined with AWL is safe and feasible for laparoscopic TME.The technique can provide satisfactory exposure of the operative field and stable operative monitoring indices. 展开更多
关键词 Laparoscopic surgery ABDOMINAL wall LIFT LOW-PRESSURE PNEUMOPERITONEUM RECTAL cancer Total mesorectal EXCISION
下载PDF
Green channel of human organ transport improved the utilization rate of Chinese citizens’donated lungs:a single-center data analysis 被引量:1
3
作者 Xiao-Shan Li chun-xiao hu +7 位作者 Feng Liu Jian huang Dong Liu Zhi-hui Yu hui-Xing Li Jin Zhao Qian-Li Ma Jing-Yu Chen 《Chinese Medical Journal》 SCIE CAS CSCD 2021年第2期222-224,共3页
To the Editor:Organ donation after the citizen’s death program was fully launched in China in 2015.According to the allocation regulations of donated organs,all donated lungs must be allocated through the China Organ... To the Editor:Organ donation after the citizen’s death program was fully launched in China in 2015.According to the allocation regulations of donated organs,all donated lungs must be allocated through the China Organ Transplant Response System(COTRS,www.cot.org.cn).[1]To fully optimize the implementation of organ transportation sharing policy and coordinate multiple government departments and social groups involved in the process,the"Green Channel of Human Organ Transport(GCHOT)"was established on May 6th,2016 in China[Supplementary Figure 1,http://links.lww.com/CM9/A431].[2]In this study,we reviewed and compared the status of lung transportation between the pre-and post-GCHOT periods based on data collected from the largest lung transplantation(LT)center in Wuxi,Jiangsu,China,with the aim of introducing the detailed process and implementation of GCHOT in China. 展开更多
关键词 CENTER FIGURE POLICY
原文传递
Lung transplantation in China between 2015 and 2018 被引量:25
4
作者 chun-xiao hu Wen-hui Ghen +7 位作者 Jian-Xing He Ge-Ning Jiang Xiao-Shan Li Dong Wei Bo Wu Ji Zhang Chen Wang Jing-Yu Chen 《Chinese Medical Journal》 SCIE CAS CSCD 2019年第23期2783-2789,共7页
Background:Lung transplantation(LT)has been demonstrated as the only effective therapy for patients with end-stage lung diseases.Increasing listed lung transplant candidates and expanding volumes of lung transplant ce... Background:Lung transplantation(LT)has been demonstrated as the only effective therapy for patients with end-stage lung diseases.Increasing listed lung transplant candidates and expanding volumes of lung transplant centers across China require wellorganized programs and registry data collection based on the large population.This study aimed to summarize and analyze the data of LT development in China.Methods:We retrospectively collected and analyzed data from the China Lung Transplantation Registry(CLuTR).Key data were reported from the registry with transplant types,indications,donor and recipient characteristics,outcomes and survival.The survival<30 days,1-year and 3-year survival rates were estimated with risk factors identified.Results:CLuTR contained data from 1053 lung transplants performed through January 1st,2015 to December 31st,2018 reported by 18 registered transplant centers.The largest category of diagnosis before transplantation was idiopathic interstitial pneumonitis.The total<30 days,1-year and 3-year survival rates in CLuTR were 81.45%,70.11%,and 61.16%with discrepancy by indications.Large proportion of recipients who were more than 60 years old required higher standard of care.Infection-related complications resulted in more death events in the early post-surgery periods.New York Heart Association grading at listing,extra-corporeal membrane oxygenation usage peri-transplantation,allograft dysfunction(primary graft dysfunction>Grade 0),renal insufficiency(estimated glomerular filtration rate<60 mL min_11.73 m^2),were independently associated with a higher risk for 3-year mortality in the entire cohort.Conclusions:Facing more end-stage of lung diseases and comorbidities,this study analyzed the outcomes and survival of LT recipients in China.Further prospectively stratified analyses with longer follow-up will be needed. 展开更多
关键词 Lung transplantation China Organ donation SURVIVAL QUALITY
原文传递
Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis 被引量:20
5
作者 Jing-Yu Chen Kun Qiao +22 位作者 Feng Liu Bo Wu Xin Xu Guo-Qing Jiao Rong-Guo Lu hui-Xing Li Jin Zhao Jian huang Yi Yang Xiao-Jie Lu Jia-Shu Li Shu-Yun Jiang Da-Peng Wang chun-xiao hu Gui-Long Wang Dong-Xiao huang Guo-hui Jiao Dong Wei Shu-Gao Ye Jian-An huang Li Zhou Xiao-Qin Zhang Jian-Xing He 《Chinese Medical Journal》 SCIE CAS CSCD 2020年第12期1390-1396,共7页
Background:Critical patients with the coronavirus disease 2019(COVID-19),even those whose nucleic acid test results had turned negative and those receiving maximal medical support,have been noted to progress to irreve... Background:Critical patients with the coronavirus disease 2019(COVID-19),even those whose nucleic acid test results had turned negative and those receiving maximal medical support,have been noted to progress to irreversible fatal respiratory failure.Lung transplantation(LT)as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients.Methods:From February 10 to March 10,2020,three male patients were urgently assessed and listed for transplantation.After conducting a full ethical review and after obtaining assent from the family of the patients,we performed three LT procedures for COVID-19 patients with illness durations of more than one month and extremely high sequential organ failure assessment scores.Results:Two of the three recipients survived post-LT and started participating in a rehabilitation program.Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved.The pathological results of the explanted lungs were concordant with the critical clinical manifestation,and provided insight towards better understanding of the disease.Government health affair systems,virology detection tools,and modern communication technology all play key roles towards the survival of the patients and their rehabilitation.Conclusions:LT can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis.If confirmed positive-turned-negative virology status without organ dysfunction that could contraindicate LT,LT provided the final option for these patients to avoid certain death,with proper protection of transplant surgeons and medical staffs.By ensuring instant seamless care for both patients and medical teams,the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained. 展开更多
关键词 Coronavirus disease 2019 Lung transplantation Acute respiratory distress syndrome Pulmonary fibrosis Sequential Organ Failure Assessment score
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部